Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

India-Based KriGen Pharmaceuticals Chooses Lillington, North Carolina, for U.S. Operations

06/06/2019
KriGen Pharmaceuticals, an India-based pharmaceutical company, will invest $7 million to locate its first U.S. production plant in Lillington, North Carolina. The project is expected to create 100 jobs in Harnett County.

A privately held Indian company, KriGen Pharmaceuticals will manufacture medical IV bags and liquid injectables in its new 55,000 square-foot state-of-the-art facility. The company aims to improve quality of life for patients with affordable pharmaceutical solutions and services through innovation and technology. KriGen researches and develops healthcare solutions and high-quality pharmaceuticals.

“The vision of KriGen Pharmaceuticals is to improve the quality of human lives by providing affordable pharmaceutical formulations based on innovation and technology,” said CFO for KriGen Pharmaceuticals, Dhruvkumar Patel. “We aspire to be the best healthcare solution providers with finished product formulation solutions for generic, as well as branded, pharmaceutical companies.”

“As a biomanufacturing trailblazer, North Carolina is poised for companies like KriGen,” said Secretary of Commerce Anthony M. Copeland. “Their footprint in Harnett County will have a great economic impact in and around their chosen site.”

The North Carolina Department of Commerce and the Economic Development Partnership of N.C. were instrumental in supporting the company’s decision to expand to the state.

A performance-based grant of $200,000 from the One North Carolina Fund will help facilitate KriGen Pharmaceutical’s new operation in North Carolina. The One NC Fund provides financial assistance to local governments to help attract economic investment and to create jobs. Companies receive no money upfront and must meet job creation and capital investment targets to qualify for payment. All One NC grants require a matching grant from local governments and any award is contingent upon that condition being met.

“North Carolina is a leader in life science research and development, as well as pharmaceutical manufacturing,” said Governor Roy Cooper. “With our strong workforce and room to grow, KriGen has made a great choice for its first North American manufacturing operation and we welcome the new jobs and investment to Harnett County.”

In addition to N.C. Commerce and the EDPNC, other key partners in the project include the North Carolina General Assembly, North Carolina Community College System, North Carolina Biotechnology Center, Harnett County, Harnett County’s Economic Development Office and the Town of Lillington.

Exclusive Research